PreprintCited by 1Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model OrganismsSingle-cell and spatial transcriptomics

Circulating Cell Type Senescence Signatures Reveal High-Resolution Health Status and Trajectories in Human Longitudinal Studies

Open access
Olinger, Bradley, Anerillas, Carlos, Herman, Allison B., Tsitsipatis, Dimitrios, Banarjee, Reema, Tanaka, Toshiko, Candia, Julian, Maragkakis, Manolis +7 more·2026·medRxiv

Abstract

SUMMARY: Cellular senescence increases in frequency with age and is implicated in age-related pathologies, and identifying circulating biomarkers of senescence holds great diagnostic potential. Circulating senescence signatures are predictive of many age-related traits and diseases, though cell type-specific senescence signatures have not been comprehensively explored. In this study, senescence signatures from the Senescence Catalog (SenCat), including 14 human cell types such as peripheral blood mononuclear cells, renal epithelial cells, vascular smooth muscle cells, among others, are examined for their clinical relevance in circulation in two longitudinal studies: 1,275 participants of the Baltimore Longitudinal Study of Aging (BLSA) and 997 participants of the Invecchiare in Chianti (InCHIANTI) study. Notably, pooled senescence proteins outperformed non-senescence proteins in predicting many clinical parameters such as age and hypertension, and in many instances cell type senescence signatures mapped most strongly to their corresponding health domain. Importantly, the immune cell senescence signature is associated with future onset of several diseases such as diabetes. This study demonstrates that circulating cell type-specific biomarkers of senescence can reveal higher resolution health status than previously attained. HIGHLIGHTS: Circulating senescence associated proteins tend to outperform non-senescence proteins as biomarkers of clinical phenotypes in two independent longitudinal studies. A core senescence signature developed from 14 human cell types predicted a range of clinical phenotypes during aging. Cell type senescence signatures more strongly associated with their corresponding health domains. The immune cell senescence signature and others were associated with mortality and diabetes onset, highlighting relevance for assessing health trajectories.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.64898/2026.02.06.26345739

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The companion study shows that SenCat's protein component can identify clinically relevant senotype-specific signatures in human plasma proteomic data, with better performance and tissue resolution than earlier reports.

    “our companion study19 demonstrates that the proteomic component of SenCat can be leveraged to identify clinically relevant senotype-specific signatures in human plasma proteomic data, with greater performance and tissue-resolution than previously reported.”

    From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [19]

    The Results describe clinically relevant cell type-specific signatures derived from SenCat proteins and measured in human plasma; the Discussion says they offer higher-resolution insights into health status than previously achieved. The reported performance advantage is over non-senescence proteins in predicting clinical traits, not over earlier reports. The copy therefore does not support the claim of better performance than previously reported. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • A companion study connected blood markers of specific senotypes to particular age-related conditions.

    “We have validated its usefulness in a companion study that linked senotype-specific senescence markers in blood to specific age-associated conditions.19”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 57

  1. [1]Campisi J., and di Fagagna F.D. (2007). Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Bio 8, 729– 740. 10.1038/nrm2233. 17667954 · DOI · Paper page
  2. [2]Coppe J.P., Desprez P.Y., Krtolica A., and Campisi J. (2010). The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 5, 99– 118. 10.1146/annurev-pathol-121808-102144. 20078217 PMC4166495 · DOI · Paper page
  3. [4]Basisty N., Kale A., Patel S., Campisi J., and Schilling B. (2020). The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications. Expert Rev Proteomics 17, 297– 308. 10.1080/14789450.2020.1766976. 32425074 PMC7416420 · DOI · Paper page
  4. [5]Basisty N., Kale A., Jeon O.H., Kuehnemann C., Payne T., Rao C., Holtz A., Shah S., Sharma V., Ferrucci L., (2020). A proteomic atlas of senescence-associated secretomes for aging biomarker development. PLoS Biol 18, e3000599. 10.1371/journal.pbio.3000599. 31945054 PMC6964821 · DOI · Paper page
  5. [6]Schafer M.J., Zhang X., Kumar A., Atkinson E.J., Zhu Y., Jachim S., Mazula D.L., Brown A.K., Berning M., Aversa Z., (2020). The senescence-associated secretome as an indicator of age and medical risk. JCI Insight 5. 10.1172/jci.insight.133668. PMC7406245 32554926 · DOI · Paper page
  6. [8]Althubiti M., Lezina L., Carrera S., Jukes-Jones R., Giblett S.M., Antonov A., Barlev N., Saldanha G.S., Pritchard C.A., Cain K., and Macip S. (2014). Characterization of novel markers of senescence and their prognostic potential in cancer. Cell Death Dis 5, e1528. 10.1038/cddis.2014.489. PMC4260747 25412306 · DOI · Paper page
  7. [9]Olinger B., Banarjee R., Dey A., Tsitsipatis D., Tanaka T., Ram A., Nyunt T., Daya G.N., Peng Z., Shrivastava M., (2025). The secretome of senescent monocytes predicts age-related clinical outcomes in humans. Nat Aging. 10.1038/s43587-025-00877-3. PMC12276915 40461807 · DOI
  8. [10]Tanaka T., Biancotto A., Moaddel R., Moore A.Z., Gonzalez-Freire M., Aon M.A., Candia J., Zhang P., Cheung F., Fantoni G., (2018). Plasma proteomic signature of age in healthy humans. Aging Cell 17, e12799. 10.1111/acel.12799. 29992704 PMC6156492 · DOI · Paper page
  9. [11]St Sauver J.L., Weston S.A., Atkinson E.J., Mc Gree M.E., Mielke M.M., White T.A., Heeren A.A., Olson J.E., Rocca W.A., Palmer A.K., (2023). Biomarkers of cellular senescence and risk of death in humans. Aging Cell 22, e14006. 10.1111/acel.14006. 37803875 PMC10726868 · DOI
  10. [12]Arauna D., Garcia F., Rodriguez-Manas L., Marrugat J., Saez C., Alarcon M., Wehinger S., Espinosa-Parrilla Y., Palomo I., and Fuentes E. (2020). Older adults with frailty syndrome present an altered platelet function and an increased level of circulating oxidative stress and mitochondrial dysfunction biomarker GDF-15. Free Radic Biol Med 149, 64– 71. 10.1016/j.freeradbiomed.2020.01.007. 31926293 · DOI
  11. [14]Osawa Y., Semba R.D., Fantoni G., Candia J., Biancotto A., Tanaka T., Bandinelli S., and Ferrucci L. (2020). Plasma proteomic signature of the risk of developing mobility disability: A 9-year follow-up. Aging Cell 19, e13132. 10.1111/acel.13132. 32157804 PMC7189986 · DOI
  12. [15]Yang J., Kong C., Jia L., Li T., Quan M., Li Y., Lyu D., Li F., Jin H., Li Y., (2021). Association of accelerated long-term forgetting and senescence-related bloodborne factors in asymptomatic individuals from families with autosomal dominant Alzheimer's disease. Alzheimers Res Ther 13, 107. 10.1186/s13195-021-00845-0. 34044860 PMC8157428 · DOI
  13. [16]Serre-Miranda C., Roque S., Santos N.C., Costa P., Sousa N., Palha J.A., and Correia-Neves M. (2020). Cognition Is Associated With Peripheral Immune Molecules in Healthy Older Adults: A Cross-Sectional Study. Front Immunol 11, 2045. 10.3389/fimmu.2020.02045. 32983153 PMC7493640 · DOI
  14. [17]Lu W.H., Guyonnet S., Martinez L.O., Lucas A., Parini A., Vellas B., and de Souto Barreto P. (2023). Association between aging-related biomarkers and longitudinal trajectories of intrinsic capacity in older adults. Geroscience 45, 3409– 3418. 10.1007/s11357-023-00906-2. 37620614 PMC10643641 · DOI
  15. [18]Yang J., Zhou Y., Wang T., Li N., Chao Y., Gao S., Zhang Q., Wu S., Zhao L., and Dong X. (2024). A multi-omics study to monitor senescence-associated secretory phenotypes of Alzheimer's disease. Ann Clin Transl Neurol 11, 1310– 1324. 10.1002/acn3.52047. 38605603 PMC11093245 · DOI
  16. [19]Campeau A., Mills R.H., Stevens T., Rossitto L.A., Meehan M., Dorrestein P., Daly R., Nguyen T.T., Gonzalez D.J., Jeste D.V., and Hook V. (2022). Multi-omics of human plasma reveals molecular features of dysregulated inflammation and accelerated aging in schizophrenia. Mol Psychiatry 27, 1217– 1225. 10.1038/s41380-021-01339-z. 34741130 PMC9054664 · DOI
  17. [20]Fitzpatrick M.E., Singh V., Bertolet M., Lucht L., Kessinger C., Michel J., Logar A., Weinman R., McMahon D., Norris K.A., (2014). Relationships of pulmonary function, inflammation, and T-cell activation and senescence in an HIV-infected cohort. AIDS 28, 2505– 2515. 10.1097/QAD.0000000000000471. 25574956 PMC4403864 · DOI
  18. [21]Aversa Z., Atkinson E.J., Carmona E.M., White T.A., Heeren A.A., Jachim S.K., Zhang X., Cummings S.R., Chiarella S.E., Limper A.H., and LeBrasseur N.K. (2023). Biomarkers of cellular senescence in idiopathic pulmonary fibrosis. Respir Res 24, 101. 10.1186/s12931-023-02403-8. 37029417 PMC10080755 · DOI
  19. [22]Bian X., Griffin T.P., Zhu X., Islam M.N., Conley S.M., Eirin A., Tang H., O'Shea P.M., Palmer A.K., McCoy R.G., (2019). Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy. BMJ Open Diabetes Res Care 7, e000720. 10.1136/bmjdrc-2019-000720. PMC6936543 31908790 · DOI
  20. [23]Yamaguchi Y., Zampino M., Tanaka T., Bandinelli S., Osawa Y., Ferrucci L., and Semba R.D. (2021). Elevated Plasma Growth and Differentiation Factor 15 Predicts Incident Anemia in Older Adults Aged 60 Years and Older. J Gerontol A Biol Sci Med Sci 76, 1192– 1197. 10.1093/gerona/glaa324. 33367500 PMC8202153 · DOI
  21. [24]Kudlova N., De Sanctis J.B., and Hajduch M. (2022). Cellular Senescence: Molecular Targets, Biomarkers, and Senolytic Drugs. Int J Mol Sci 23. 10.3390/ijms23084168. PMC9028163 35456986 · DOI
  22. [27]Brull V., Burak C., Stoffel-Wagner B., Wolffram S., Nickenig G., Muller C., Langguth P., Alteheld B., Fimmers R., Naaf S., (2015). Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial. Br J Nutr 114, 1263– 1277. 10.1017/S0007114515002950. 26328470 PMC4594049 · DOI
  23. [29]Jahns L., Conrad Z., Johnson L.K., Whigham L.D., Wu D., and Claycombe-Larson K.J. (2018). A diet high in carotenoid-rich vegetables and fruits favorably impacts inflammation status by increasing plasma concentrations of IFN-alpha2 and decreasing MIP-1beta and TNF-alpha in healthy individuals during a controlled feeding trial. Nutr Res 52, 98– 104. 10.1016/j.nutres.2018.02.005. 29551222 · DOI
  24. [30]Justice J.N., Leng X.I., LeBrasseur N.K., Tchkonia T., Kirkland J.L., Mitin N., Liu Y., Kritchevsky S.B., Nicklas B.J., and Ding J. (2024). Caloric Restriction Intervention Alters Specific Circulating Biomarkers of the Senescence-Associated Secretome in Middle-Aged and Older Adults With Obesity and Prediabetes in an 18-Week Randomized Controlled Trial. J Gerontol A Biol Sci Med Sci 79. 10.1093/gerona/glad214. PMC10733170 37738560 · DOI
  25. [31]Ravussin E., Redman L.M., Rochon J., Das S.K., Fontana L., Kraus W.E., Romashkan S., Williamson D.A., Meydani S.N., Villareal D.T., (2015). A 2-Year Randomized Controlled Trial of Human Caloric Restriction: Feasibility and Effects on Predictors of Health Span and Longevity. J Gerontol A Biol Sci Med Sci 70, 1097– 1104. 10.1093/gerona/glv057. 26187233 PMC4841173 · DOI · Paper page
  26. [32]Hohensinner P.J., Kaun C., Ebenbauer B., Hackl M., Demyanets S., Richter D., Prager M., Wojta J., and Rega-Kaun G. (2018). Reduction of Premature Aging Markers After Gastric Bypass Surgery in Morbidly Obese Patients. Obes Surg 28, 2804– 2810. 10.1007/s11695-018-3247-3. 29693219 PMC6132736 · DOI
  27. [33]Wong G.C.L., Ng T.K.S., Lee J.L., Lim P.Y., Chua S.K.J., Tan C., Chua M., Tan J., Lee S., Sia A., (2021). Horticultural Therapy Reduces Biomarkers of Immunosenescence and Inflammaging in Community-Dwelling Older Adults: A Feasibility Pilot Randomized Controlled Trial. J Gerontol A Biol Sci Med Sci 76, 307– 317. 10.1093/gerona/glaa271. 33070170 PMC7812436 · DOI
  28. [35]Lehallier B., Gate D., Schaum N., Nanasi T., Lee S.E., Yousef H., Moran Losada P., Berdnik D., Keller A., Verghese J., (2019). Undulating changes in human plasma proteome profiles across the lifespan. Nat Med 25, 1843– 1850. 10.1038/s41591-019-0673-2. 31806903 PMC7062043 · DOI · Paper page
  29. [37]Wu Y.T., Niubo A.S., Daskalopoulou C., Moreno-Agostino D., Stefler D., Bobak M., Oram S., Prince M., and Prina M. (2021). Sex differences in mortality: results from a population-based study of 12 longitudinal cohorts. CMAJ 193, E361– E370. 10.1503/cmaj.200484. 33722827 PMC8096404 · DOI
  30. [39]Ng M., and Hazrati L.N. (2022). Evidence of sex differences in cellular senescence. Neurobiol Aging 120, 88– 104. 10.1016/j.neurobiolaging.2022.08.014. 36166919 · DOI
  31. [40]Hyder A., Sheta B., Eissa M., and Schrezenmeir J. (2024). Silencing the FABP3 gene in insulin-secreting cells reduces fatty acid uptake and protects against lipotoxicity. Acta Diabetol 61, 1577– 1588. 10.1007/s00592-024-02325-x. 38960943 PMC11628584 · DOI
  32. [41]Rodriguez-Calvo R., Granado-Casas M., Perez-Montes de Oca A., Julian M.T., Domingo M., Codina P., Santiago-Vacas E., Cediel G., Julve J., Rossell J., (2023). Fatty Acid Binding Proteins 3 and 4 Predict Both All-Cause and Cardiovascular Mortality in Subjects with Chronic Heart Failure and Type 2 Diabetes Mellitus. Antioxidants (Basel) 12. 10.3390/antiox12030645. PMC10044995 36978893 · DOI
  33. [42]Lau E., Carroll E., Callender L., Hood G., Berryman V., Pattrick M., Finer S., Hitman G., Ackland G., and Henson S. (2019). Type 2 diabetes is associated with the accumulation of senescent T cells. Clin Exp Immunol 197, 205– 213. 10.1111/cei.13344. 31251396 PMC6642873 · DOI
  34. [43]Gustafson B., Nerstedt A., and Smith U. (2019). Reduced subcutaneous adipogenesis in human hypertrophic obesity is linked to senescent precursor cells. Nat Commun 10, 2757. 10.1038/s41467-019-10688-x. 31227697 PMC6588633 · DOI
  35. [44]Narasimhan A., Flores R.R., Camell C.D., Bernlohr D.A., Robbins P.D., and Niedernhofer L.J. (2022). Cellular Senescence in Obesity and Associated Complications: a New Therapeutic Target. Curr Diab Rep 22, 537– 548. 10.1007/s11892-022-01493-w. 36239841 PMC10123542 · DOI
  36. [45]Bolton K., Segal D., McMillan J., Jowett J., Heilbronn L., Abberton K., Zimmet P., Chisholm D., Collier G., and Walder K. (2008). Decorin is a secreted protein associated with obesity and type 2 diabetes. Int J Obes (Lond) 32, 1113– 1121. 10.1038/ijo.2008.41. 18414424 · DOI
  37. [46]Cavusoglu E., Marmur J.D., Chhabra S., Hojjati M.R., Yanamadala S., Chopra V., Eng C., and Jiang X.C. (2015). Elevated baseline plasma phospholipid protein (PLTP) levels are an independent predictor of long-term all-cause mortality in patients with diabetes mellitus and known or suspected coronary artery disease. Atherosclerosis 239, 503– 508. 10.1016/j.atherosclerosis.2015.02.017. 25710294 PMC4361262 · DOI
  38. [47]He Y., Xie W., Li H., Jin H., Zhang Y., and Li Y. (2021). Cellular Senescence in Sarcopenia: Possible Mechanisms and Therapeutic Potential. Front Cell Dev Biol 9, 793088. 10.3389/fcell.2021.793088. 35083219 PMC8784872 · DOI
  39. [48]Sousa-Victor P., Gutarra S., Garcia-Prat L., Rodriguez-Ubreva J., Ortet L., Ruiz-Bonilla V., Jardi M., Ballestar E., Gonzalez S., Serrano A.L., (2014). Geriatric muscle stem cells switch reversible quiescence into senescence. Nature 506, 316– 321. 10.1038/nature13013. 24522534 · DOI · Paper page
  40. [49]Garcia-Prat L., Martinez-Vicente M., Perdiguero E., Ortet L., Rodriguez-Ubreva J., Rebollo E., Ruiz-Bonilla V., Gutarra S., Ballestar E., Serrano A.L., (2016). Autophagy maintains stemness by preventing senescence. Nature 529, 37– 42. 10.1038/nature16187. 26738589 · DOI · Paper page
  41. [50]Huang Y.M., Ma Y.H., Gao P.Y., Wang Z.B., Huang L.Y., Hou J.H., Tan L., and Yu J.T. (2023). Plasma beta(2)-microglobulin and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact older adults: the CABLE study. Alzheimers Res Ther 15, 69. 10.1186/s13195-023-01217-6. 37005674 PMC10067214 · DOI
  42. [51]Jia H., Huang W., Liu C., Tang S., Zhang J., Chen C., Tian Y., and Zhong W. (2022). Immunosenescence is a therapeutic target for frailty in older adults: a narrative review. Ann Transl Med 10, 1142. 10.21037/atm-22-4405. 36388790 PMC9652526 · DOI
  43. [52]Liu Z., Liang Q., Ren Y., Guo C., Ge X., Wang L., Cheng Q., Luo P., Zhang Y., and Han X. (2023). Immunosenescence: molecular mechanisms and diseases. Signal Transduct Target Ther 8, 200. 10.1038/s41392-023-01451-2. 37179335 PMC10182360 · DOI
  44. [55]Salech F., SanMartin C.D., Concha-Cerda J., Romero-Hernandez E., Ponce D.P., Liabeuf G., Rogers N.K., Murgas P., Bruna B., More J., and Behrens M.I. (2022). Senescence Markers in Peripheral Blood Mononuclear Cells in Amnestic Mild Cognitive Impairment and Alzheimer's Disease. Int J Mol Sci 23. 10.3390/ijms23169387. PMC9409141 36012652 · DOI
  45. [56]Lekva T., Ueland T., Halvorsen B., Murphy S.L., Dyrhol-Riise A.M., Tveita A., Finbraten A.K., Mathiessen A., Muller K.E., Aalokken T.M., (2022). Markers of cellular senescence is associated with persistent pulmonary pathology after COVID-19 infection. Infect Dis (Lond) 54, 918– 923. 10.1080/23744235.2022.2113135. 35984738 · DOI
  46. [57]Schaenman J.M., Pickering H., Reed E.F., Rossetti M., Seligman B., Weigt S.S., Shino M., Sayah D., Belperio J., Hu A., (2025). T cell immune senescence is associated with frailty and sarcopenia in lung transplant candidates. JHLT Open 7, 100199. 10.1016/j.jhlto.2024.100199. 40144851 PMC11935382 · DOI
  47. [58]Imanishi T., Hano T., and Nishio I. (2005). Estrogen reduces endothelial progenitor cell senescence through augmentation of telomerase activity. J Hypertens 23, 1699– 1706. 10.1097/01.hjh.0000176788.12376.20. 16093915 · DOI
  48. [59]Faubion L., White T.A., Peterson B.J., Geske J.R., LeBrasseur N.K., Schafer M.J., Mielke M.M., and Miller V.M. (2020). Effect of menopausal hormone therapy on proteins associated with senescence and inflammation. Physiol Rep 8, e14535. 10.14814/phy2.14535. 32857481 PMC7453781 · DOI
  49. [61]Friedman J., Hastie T., and Tibshirani R. (2010). Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Softw 33, 1– 22. 20808728 PMC2929880
  50. [63]Tingley D., Yamamoto T., Hirose K., Keele L., and Imai K. (2014). Mediation: R Package for Causal Mediation Analysis. Journal of Statistical Software 59, 1– 38.26917999
  51. [64]Ferrucci L. (2008). The Baltimore Longitudinal Study of Aging (BLSA): a 50-year-long journey and plans for the future. J Gerontol A Biol Sci Med Sci 63, 1416– 1419. 10.1093/gerona/63.12.1416. 19126858 PMC5004590 · DOI
  52. [65]Tanaka T., Kafyra M., Jin Y., Chia C.W., Dedoussis G.V., Talegawkar S.A., and Ferrucci L. (2022). Quality Specific Associations of Carbohydrate Consumption and Frailty Index. Nutrients 14. 10.3390/nu14235072. PMC9736578 36501101 · DOI
  53. [67]Candia J., Daya G.N., Tanaka T., Ferrucci L., and Walker K.A. (2022). Assessment of variability in the plasma 7k SomaScan proteomics assay. Sci Rep 12, 17147. 10.1038/s41598-022-22116-0. 36229504 PMC9561184 · DOI
  54. [68]Reilly L., Lara E., Ramos D., Li Z., Pantazis C.B., Stadler J., Santiana M., Roberts J., Faghri F., Hao Y., (2023). A fully automated FAIMS-DIA mass spectrometry-based proteomic pipeline. Cell Rep Methods 3, 100593. 10.1016/j.crmeth.2023.100593. 37729920 PMC10626189 · DOI
  55. [69]Li Z., Weller C.A., Shah S., Johnson N.L., Hao Y., Jarreau P.B., Roberts J., Guha D., Bereda C., Klaisner S., (2025). ProtPipe: A Multifunctional Data Analysis Pipeline for Proteomics and Peptidomics. Genomics Proteomics Bioinformatics 22. 10.1093/gpbjnl/qzae083. PMC11842048 39576693 · DOI
  56. [72]Groemping U. (2006). Relative Importance for Linear Regression in R: The Package relaimpo. Journal of Statistical Software 17, 1– 27.
  57. [73]Wu T., Hu E., Xu S., Chen M., Guo P., Dai Z., Feng T., Zhou L., Tang W., Zhan L., (2021). clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb) 2, 100141. 10.1016/j.xinn.2021.100141. 34557778 PMC8454663 · DOI

Cited by

Sorted by citations

Authors
Olinger, B., Anerillas, C., Herman, A. B., Tsitsipatis, D., Banarjee, R., Tanaka, T., Candia, J., Maragkakis, M., Bandinelli, S., Walker, K. A., Simonsick, E. M., Qi, Y. A., Ferrucci, L., Gorospe, M., & Basisty, N.
Affiliations
  • Johns Hopkins University (US)
  • Consejo Superior de Investigaciones Científicas (ES)
  • National Institute on Aging (US)
  • Translational Gerontology Branch, National Institute on Aging, NIH, Baltimore, Maryland, USA
  • National Institutes of Health (US)
  • Geriatric Unit, Azienda Sanitaria toscana centro, Firenze, Italy
Corresponding author
Basisty, Nathan
Venue
medRxiv
Publisher
openRxiv
Published
2026-02-09
OpenAlex
W7128438450
Cited by
0
References
11
Type
posted content
Language
en
Open access
Locations
  • medRxiv (acceptedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
Funders
  • U.S. Department of Health and Human Services
  • National Institutes of Health (NIA U54 AG079779)
  • National Institute on Aging (U54AG079779)
  • Common Fund
Topics
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
Keywords
cellular senescence, aging, health trajectories, hypertension, diabetes onset, mortality, peripheral blood mononuclear cells, vascular smooth muscle cells, renal epithelial cells, Baltimore Longitudinal Study of Aging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review